X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2985) 2985
Publication (413) 413
Newsletter (51) 51
Book Review (40) 40
Newspaper Article (39) 39
Book Chapter (15) 15
Magazine Article (5) 5
Conference Proceeding (3) 3
Data Set (2) 2
Transcript (2) 2
Web Resource (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2397) 2397
tenofovir (2200) 2200
index medicus (1915) 1915
female (1412) 1412
hiv infections - drug therapy (1391) 1391
male (1379) 1379
adult (1208) 1208
adenine - analogs & derivatives (1176) 1176
infectious diseases (1125) 1125
hiv (996) 996
middle aged (954) 954
anti-hiv agents - adverse effects (887) 887
adenine - adverse effects (728) 728
anti-hiv agents - therapeutic use (718) 718
tenofovir disoproxil fumarate (671) 671
adenine - therapeutic use (644) 644
pharmacology & pharmacy (629) 629
organophosphonates - adverse effects (624) 624
emtricitabine (618) 618
antiretroviral therapy (598) 598
treatment outcome (596) 596
human immunodeficiency virus--hiv (583) 583
immunology (576) 576
organophosphonates - therapeutic use (554) 554
drug therapy (529) 529
anti-hiv agents - administration & dosage (528) 528
hiv infection (491) 491
antiviral agents (484) 484
lamivudine (476) 476
hepatitis b (449) 449
therapy (446) 446
drug therapy, combination (425) 425
safety (416) 416
virology (416) 416
adenine - administration & dosage (415) 415
health aspects (410) 410
antiviral agents - therapeutic use (405) 405
antiretroviral drugs (396) 396
hepatitis b, chronic - drug therapy (387) 387
risk factors (376) 376
organophosphonates - administration & dosage (363) 363
gastroenterology & hepatology (348) 348
viral load (337) 337
hiv infections - complications (318) 318
young adult (313) 313
aids/hiv (310) 310
deoxycytidine - analogs & derivatives (306) 306
disoproxil fumarate (306) 306
infection (305) 305
efavirenz (302) 302
highly active antiretroviral therapy (301) 301
hiv infections - virology (301) 301
microbiology (292) 292
care and treatment (289) 289
prevention (287) 287
hepatitis (283) 283
dosage and administration (279) 279
reverse transcriptase inhibitors - adverse effects (278) 278
virus diseases (274) 274
aids (271) 271
research (271) 271
adolescent (266) 266
efficacy (266) 266
double-blind (264) 264
analysis (263) 263
clinical trials (259) 259
aged (252) 252
acquired immune deficiency syndrome--aids (251) 251
hiv-1 - drug effects (251) 251
reverse transcriptase inhibitors - therapeutic use (250) 250
tenofovir - therapeutic use (250) 250
patients (246) 246
tenofovir - adverse effects (245) 245
drug combinations (241) 241
hiv-infected patients (241) 241
hiv infections - prevention & control (240) 240
infections (237) 237
antiviral agents - adverse effects (234) 234
pharmacokinetics (229) 229
retrospective studies (226) 226
hepatitis b virus (223) 223
hiv-1 (223) 223
cd4 lymphocyte count (220) 220
entecavir (216) 216
lamivudine - therapeutic use (213) 213
adefovir dipivoxil (212) 212
human-immunodeficiency-virus (212) 212
antiretroviral therapy, highly active - adverse effects (211) 211
pregnancy (207) 207
human immunodeficiency virus (203) 203
drug resistance, viral (198) 198
medicine (198) 198
protease inhibitors (198) 198
risk (194) 194
article (193) 193
antiretroviral agents (190) 190
toxicity (186) 186
medicine, general & internal (182) 182
deoxycytidine - therapeutic use (181) 181
medicine & public health (179) 179
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2994) 2994
Spanish (40) 40
German (28) 28
French (18) 18
Korean (5) 5
Turkish (3) 3
Italian (2) 2
Arabic (1) 1
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Japanese (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9581, pp. 12 - 14
Journal Article
世界肝病学杂志:英文版(电子版), ISSN 1948-5182, 2017, Volume 9, Issue 5, pp. 227 - 241
Oral nucleoside/nucleotide analogues(NAs) are currently the backbone of chronic hepatitis B(CHB) infection treatment. They are generally well-tolerated by... 
Entecavir | Lamivudine | Nucleoside/nucleotide analogues | Adverse effects | Tenofovir | Adefovir | Side effects | Adverse events | Chronic hepatitis B | Hepatitis B infection | Hepatitis B virus | Safety | Telbivudine | Review | Nucleoside | nucleotide analogues
Journal Article
Advances in Chronic Kidney Disease, ISSN 1548-5595, 2010, Volume 17, Issue 1, pp. 72 - 82
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 9/2019, Volume 39, Issue 9, pp. 835 - 846
Oral nucleoside/nucleotide analogues (NAs) have been advocated for chronic hepatitis B (CHB) treatment with good efficacy. However, less attention has been put... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | EARLY VIRAL KINETICS | NUCLEOTIDE ANALOGS | TENOFOVIR DISOPROXIL FUMARATE | ONE-YEAR TRIAL | VIRUS-DNA | POSITIVE CHRONIC HEPATITIS | ADEFOVIR DIPIVOXIL | CLINICAL-TRIALS | ENTECAVIR TREATMENT | PHARMACOLOGY & PHARMACY | CHINESE PATIENTS | Index Medicus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 12, pp. 1791 - 1801
Background. Long-term effects of abacavir (ABC)-lamivudine (3TC), compared with tenofovir (TDF)-emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus... 
HIV/AIDS | Percentage change | RNA | Spine | Bones | Bone density | Arm | Hip | Bone fractures | HIV 1 | Arts | INFECTIOUS DISEASES | EFFICACY | INITIATION | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | COMBINATION | OSTEOPOROSIS | HIV-INFECTED PATIENTS | WOMEN | THERAPY | COHORT | HEALTH | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Fractures, Bone - epidemiology | Male | Oligopeptides - adverse effects | Viral Load | Lamivudine - adverse effects | Tenofovir | Pyridines - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Atazanavir Sulfate | Adult | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | Osteoporosis - chemically induced | Anti-HIV Agents - adverse effects | Risk Factors | Organophosphonates - adverse effects | Benzoxazines - adverse effects | CD4 Lymphocyte Count | Absorptiometry, Photon | Bone Density - drug effects | HIV Infections - complications | Intention to Treat Analysis | HIV Infections - drug therapy | Fractures, Bone - chemically induced | Deoxycytidine - analogs & derivatives | Drug Combinations | Usage | Care and treatment | Ritonavir | Drug utilization | Lamivudine | Efavirenz | Prevention | Abacavir | Dosage and administration | Drug therapy, Combination | Drug therapy | HIV infection | Major and Brief Reports
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9987, pp. 2606 - 2615
Summary Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide... 
Internal Medicine | KIDNEY-DISEASE | RATES | MEDICINE, GENERAL & INTERNAL | ABACAVIR-LAMIVUDINE | BONE-MINERAL DENSITY | SAFETY | ADULTS | ANTIRETROVIRAL THERAPY | LOPINAVIR/RITONAVIR | COUNT | EXPOSURE | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
Science, ISSN 0036-8075, 9/2010, Volume 329, Issue 5996, pp. 1168 - 1174
The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of... 
Human sexual behavior | HIV infections | Antiinfectives | Gels | HIV | RESEARCH ARTICLES | Placebos | Experimentation | AIDS | Infections | Condoms | VAGINAL GEL | INDIVIDUALS | SOUTH-AFRICA | PROPHYLAXIS | IN-VITRO | TRANSMISSION | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | MALE CIRCUMCISION | RANDOMIZED CONTROLLED-TRIAL | CHALLENGES | HIV Infections - prevention & control | Anti-Infective Agents, Local - therapeutic use | Urban Population - statistics & numerical data | HIV Infections - epidemiology | Humans | Anti-Infective Agents, Local - adverse effects | Drug Resistance, Viral | Administration, Intravaginal | Viral Load | Incidence | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | HIV-1 - physiology | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Vaginal Creams, Foams, and Jellies | Rural Population - statistics & numerical data | Sexual Behavior | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | South Africa - epidemiology | Organophosphonates - adverse effects | Adenine - administration & dosage | Pregnancy | Organophosphonates - administration & dosage | Anti-Infective Agents, Local - administration & dosage | Adolescent | Patient Compliance | Pregnancy Outcome | Prevention | Anti-infective agents | Research | HIV infection
Journal Article